Back HIV/AIDS

HIV / AIDS

CROI 2013: VOICE Trial's Disappointing Result Poses Big Questions for PrEP

The failure of one of the largest trials yet conducted of HIV drug-based prevention methods poses questions for how to turn vaginal microbicides and oral pre-exposure prophylaxis (PrEP) into methods people can actually use, the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta heard today.

alt

CROI 2013: Development of Small Molecules for HIV Eradication [VIDEO]

Research towards a cure for HIV is a key theme of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), taking place this week in Atlanta. One of the many approaches under study is the use of small molecules to bring resting HIV out of latency, in an effort to ultimately eradicate the virus from the body.alt

CROI 2013: Retrovirus Conference Starts Sunday in Atlanta

The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) kicks off Sunday, March 3, at the Georgia World Congress Center in Atlanta. HIVandHepatitis.com will be on site next week to bring you breaking news coverage on HIV and hepatitis C.

Look for reports from the HIVandHepatitis.com team and our content partners at NAM/Aidsmap.com starting Monday. Sign up for our email newsletter to get the latest headlines and follow us on Twitter @HIVandHepatitis.alt

CROI 2013: Case Report of a 'Functional' HIV Cure in a Child

Researchers in the U.S. say that they have identified a case of a "functional" HIV cure in a child infected with HIV who began antiretroviral treatment within days of birth. The child has now been off treatment for over a year, and although HIV DNA has been detected at very low levels in the child’s cells, the virus is not reproducing.

alt

HIV Infection May Raise Risk of Sudden Hearing Loss

Young HIV positive people age 18 to 35 had more than twice the likelihood of sudden sensorineural hearing loss compared with their HIV negative counterparts, according to an analysis of nearly 9000 people with HIV described in the February 21, 2013, advance online edition of JAMA Otolaryngology-Head & Neck Surgery.

alt

Tenofovir, Protease Inhibitors Linked to Kidney Impairment

Use of tenofovir disoproxil fumarate (TDF) is associated with reduced kidney function, though for most people the change is small, does not progress with continued exposure, and improves after stopping the drug, according to several recently published studies. Some analyses found that certain HIV protease inhibitors can also cause kidney problems.

alt

President's HIV/AIDS Council Responds to Unjust HIV Criminalization Laws

The Presidential Advisory Council on HIV/AIDS (PACHA) passed a resolution this month stating that punishments imposed for HIV non-disclosure or exposureareout of proportion to actual harm inflicted, and that HIV criminalization is bad public health policy that fuels the epidemic.alt